Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Lutris Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Tel Aviv-yafo, Tel Aviv, Israel Founded 2015 11-50 employees For Profit

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.

Lutris Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Total Funding
$30M
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
1
Patents
13

About Lutris Pharma

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
13
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$8.82M

Company Info

Founded
2015
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
22
HQ
Tel Aviv-yafo, Tel Aviv, Israel
Region
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.1
Trend (90d)
-0.1

Lutris Pharma Funding Rounds

1 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesOrg Hq Country
1–1 of 1Show
Page 1 / 1

Lutris Pharma Key People

Founder & CEO
1
professional contacts at Lutris Pharma
Contact execs at Lutris Pharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Lutris Pharma

Loading news…

FAQs about Lutris Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.